Literature DB >> 23127136

The Ω-loop lid domain of phosphoenolpyruvate carboxykinase is essential for catalytic function.

Troy A Johnson1, Todd Holyoak.   

Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) is an essential metabolic enzyme operating in the gluconeogenesis and glyceroneogenesis pathways. Recent studies have demonstrated that the enzyme contains a mobile active site lid domain that undergoes a transition between an open, disorded conformation and a closed, ordered conformation as the enzyme progresses through the catalytic cycle. The understanding of how this mobile domain functions in catalysis is incomplete. Previous studies showed that the closure of the lid domain stabilizes the reaction intermediate and protects the reactive intermediate from spurious protonation and thus contributes to the fidelity of the enzyme. To more fully investigate the roles of the lid domain in PEPCK function, we introduced three mutations that replaced the 11-residue lid domain with one, two, and three glycine residues. Kinetic analysis of the mutant enzymes demonstrates that none of the enzyme constructs exhibit any measurable kinetic activity, resulting in a decrease in the catalytic parameters of at least 10(6). Structural characterization of the mutants in complexes representing the catalytic cycle suggests that the inactivity is due to a role for the lid domain in the formation of the fully closed state of the enzyme that is required for catalytic function. In the absence of the lid domain, the enzyme is unable to achieve the fully closed state and is rendered inactive despite possessing all of the residues and substrates required for catalytic function. This work demonstrates how enzyme catalytic function can be abolished through the alteration of conformational equilibria despite all the elements required for chemical conversion of substrates to products remaining intact.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127136      PMCID: PMC3525453          DOI: 10.1021/bi301278t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

1.  Contribution of phosphate intrinsic binding energy to the enzymatic rate acceleration for triosephosphate isomerase.

Authors:  T L Amyes; A C O'Donoghue; J P Richard
Journal:  J Am Chem Soc       Date:  2001-11-14       Impact factor: 15.419

Review 2.  What is the metabolic role of phosphoenolpyruvate carboxykinase?

Authors:  Jianqi Yang; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 3.  Omega loops: nonregular secondary structures significant in protein function and stability.

Authors:  J S Fetrow
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

4.  Phosphoenolpyruvate carboxykinase (guanosine 5'-triphosphate) from rat liver cytosol. Dual-cation requirement for the carboxylation reaction.

Authors:  G Colombo; G M Carlson; H A Lardy
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

5.  Assessment of the role of an omega loop of cholesterol oxidase: a truncated loop mutant has altered substrate specificity.

Authors:  N S Sampson; I J Kass; K B Ghoshroy
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Entropy effects on protein hinges: the reaction catalyzed by triosephosphate isomerase.

Authors:  Jingyi Xiang; Ju-yeon Jung; Nicole S Sampson
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

8.  Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition.

Authors:  Rose Mary Stiffin; Sarah M Sullivan; Gerald M Carlson; Todd Holyoak
Journal:  Biochemistry       Date:  2008-01-16       Impact factor: 3.162

9.  Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acid.

Authors:  Sarah M Sullivan; Todd Holyoak
Journal:  Biochemistry       Date:  2007-08-09       Impact factor: 3.162

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  9 in total

1.  Mycobacterium tuberculosis phosphoenolpyruvate carboxykinase is regulated by redox mechanisms and interaction with thioredoxin.

Authors:  Iva Machová; Jan Snašel; Michael Zimmermann; Daniel Laubitz; Przemyslaw Plocinski; Wulf Oehlmann; Mahavir Singh; Jiři Dostál; Uwe Sauer; Iva Pichová
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

2.  Genistein: is the multifarious botanical a natural anthelmintic too?

Authors:  V Tandon; B Das
Journal:  J Parasit Dis       Date:  2018-03-05

3.  Dynamic Acetylation of Phosphoenolpyruvate Carboxykinase Toggles Enzyme Activity between Gluconeogenic and Anaplerotic Reactions.

Authors:  Pedro Latorre-Muro; Josue Baeza; Eric A Armstrong; Ramón Hurtado-Guerrero; Francisco Corzana; Lindsay E Wu; David A Sinclair; Pascual López-Buesa; José A Carrodeguas; John M Denu
Journal:  Mol Cell       Date:  2018-09-06       Impact factor: 17.970

4.  Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.

Authors:  David R Adams; Hongjie Yuan; Todd Holyoak; Katrina H Arajs; Parvin Hakimi; Thomas C Markello; Lynne A Wolfe; Thierry Vilboux; Barbara K Burton; Karin Fuentes Fajardo; George Grahame; Conisha Holloman; Murat Sincan; Ann C M Smith; Gordon A Wells; Yan Huang; Hugo Vega; James P Snyder; Gretchen A Golas; Cynthia J Tifft; Cornelius F Boerkoel; Richard W Hanson; Stephen F Traynelis; Douglas S Kerr; William A Gahl
Journal:  Mol Genet Metab       Date:  2014-04-13       Impact factor: 4.797

5.  Phosphoenolpyruvate carboxykinase 1 gene (Pck1) displays parallel evolution between Old World and New World fruit bats.

Authors:  Lei Zhu; Qiuyuan Yin; David M Irwin; Shuyi Zhang
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  Structural and functional studies of phosphoenolpyruvate carboxykinase from Mycobacterium tuberculosis.

Authors:  Iva Machová; Jan Snášel; Jiří Dostál; Jiří Brynda; Jindřich Fanfrlík; Mahavir Singh; Ján Tarábek; Ondřej Vaněk; Lucie Bednárová; Iva Pichová
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

7.  The activating oxydianion binding domain for enzyme-catalyzed proton transfer, hydride transfer, and decarboxylation: specificity and enzyme architecture.

Authors:  Archie C Reyes; Xiang Zhai; Kelsey T Morgan; Christopher J Reinhardt; Tina L Amyes; John P Richard
Journal:  J Am Chem Soc       Date:  2015-01-20       Impact factor: 15.419

8.  Rational Engineered C-Acyltransferase Transforms Sterically Demanding Acyl Donors.

Authors:  Anna Żądło-Dobrowolska; Lucas Hammerer; Tea Pavkov-Keller; Karl Gruber; Wolfgang Kroutil
Journal:  ACS Catal       Date:  2019-12-27       Impact factor: 13.084

9.  Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy.

Authors:  Luiz Phillippe R Baptista; Vanessa Vc Sinatti; Joao Hm Da Silva; Laurent Emmanuel Dardenne; Ana Carolina Guimarães
Journal:  Adv Appl Bioinform Chem       Date:  2019-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.